Comparing the current results to its competitors, Veradigm Inc reported Revenue decrease in the 4 quarter 2024 year on year by -3.72 %, despite the revenue increase by the most of its competitors of 4.28 %, recorded in the same quarter.
Veradigm Inc , slower than the average decrease reported by the company's competitors of -23.63 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -23.63 %
Veradigm Inc 's Comment on Competition and Industry Peers
The markets for our solutions and services are highly competitive, and are characterized
by rapidly evolving technology and solution standards and user needs, as well
as frequent introduction of new solutions and services. Some of our competitors
may be more established, benefit from greater name recognition, and have substantially
greater financial, technical, and marketing resources than we do.
Additionally, many of our prospective clients have invested substantial personnel
and financial resources to implement and integrate competing solutions to ours.
As a consequence, they may be reluctant or unwilling to migrate to our solutions.
Third-party developers may be reluctant to build application services on our
platform since they have invested in other competing technology platforms.
We compete primarily with numerous types of organizations, including developers
of revenue cycle and practice management software and services, large system
integrators, IT service providers, ambulatory and acute care EHR solutions,
population health management and value-based care technologies, analytics systems,
care management solutions and post-acute solutions. We generally compete on
the basis of several factors, including breadth and depth of services (including
our open architecture and the level of solution integration across care settings),
integrated platform, regulatory compliance, reputation, reliability, accuracy,
security, client service, total cost of ownership, innovation and industry acceptance,
expertise and experience.
Moreover, we expect that competition will continue to increase as a result
of consolidation in both the IT and healthcare industries. If one or more of
our competitors or potential competitors were to merge or partner with another
of our competitors, the change in the competitive landscape could adversely
affect our ability to compete effectively.
Our principal existing competitors in these markets include, but are not limited
to (in alphabetical order) AdvancedMD, athenahealth Inc., Cerner Corporation,
Change Healthcare, CPSI (Computer Programs and Systems Inc.), CureMD Healthcare,
eClinicalWorks, Enli Health Intelligence, Epic Systems Corporation, Evolent
Health, GE Healthcare, Greenway Medical Technologies, Harris Healthcare, Healthagen,
Health Catalyst, Homecare Homebase (part of Hearst Health network), IBM Watson
Health, IQVIA, Kareo, MEDHOST, Inc., Meditech (Medical Information Technology,
Inc.), Navicure/Zirmed, NaviHealth (a Cardinal Health company), nThrive, Optum,
Philips Wellcentive, Premier Inc., Quadramed, Quality Systems, Inc., Roper Industries,
T-System, The TriZetto Group, Inc. (a division of Cognizant Technology Solutions,
Inc.) and Wellsoft Corporation.
February 27, 2024
Veradigm Inc. (NASDAQ: MDRX), a prominent provider of healthcare data and technology solutions, recently announced a delay in filing its annual and quarterly reports. While the company strives to address its financial restatement process, its competitor, Allscripts Healthcare Solutions Inc, reported a significant decrease in revenue during the third quarter of 2022, in contrast to its competitors revenue growth.Veradigm s Financial Restatement Process:Veradigm Inc. provided an update stating that it does not anticipate filing its Annual Report on Form 10-K for the year ended December 31, 2022, and its Quarterly Reports on Form 10-Q for the quarters ending March 31, 2023, June 30, 2023, and September 30, 202...
January 20, 2024
Veradigm Inc. (NASDAQ: MDRX), a prominent player in the healthcare solutions industry, is currently facing a class action lawsuit that alleges accounting fraud. This article explores the key details surrounding the lawsuit and provides an analysis of its potential impact on Veradigm and its investors. Background: Hagens Berman, a respected law firm, has encouraged Veradigm investors who have suffered substantial losses to submit their claims before the January 22nd deadline. The lawsuit claims that Veradigm engaged in fraudulent accounting practices, which led to significant financial losses for investors. As such, it is crucial to analyze the context in which this lawsuit is being filed and its potential im...
January 10, 2024
Veradigm Inc., a renowned provider of healthcare data and technology solutions, recently unveiled its reinvigorated leadership team. Dr. Shih-Yin Ho, serving as the Interim CEO, and Lee Westerfield, as the Interim CFO, presented Veradigm s vision, business strategies, and innovation plans at the J.P. Morgan Healthcare Conference. Additionally, they provided an updated fiscal 2023 financial outlook, shedding light on the company s potential growth trajectory. This article delves into Veradigm s recent developments and explores how they stack up against their competitors.Veradigm s Vision and Operational Focus:In their presentation, Dr. Ho and Mr. Westerfield discussed Veradigm s mission to revolutionize the h...
December 11, 2023
Veradigm Enhances Independent Practice Financial Management with AI for Practice Fusion Billing Services Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, has recently unveiled a new addition to its services, a conversational artificial intelligence (AI) agent for Practice Fusion Billing Services. This enhanced feature aims to streamline the billing process and optimize financial management for independent healthcare providers. The integration of AI technology into the Practice Fusion Billing Services offers a revolutionary way for healthcare providers to manage their billing processes. The conversational AI agent is designed to quickly address any queries ...
Aspen Technology Inc operates on a software-centric business model, offering advanced analytics and automation solutions to various industries including energy, chemicals, engineering, and pharma. The company primarily generates revenue through the sale of licenses, maintenance, and customer support services for their software products. By leveraging their expertise in process optimization and data analytics, Aspen Technology aims to help clients achieve operational excellence, improve efficiency, and maximize profitability.
Optimizerx Corp's business model revolves around providing a platform that connects pharmaceutical companies, healthcare providers, and patients. The company aims to enhance medication adherence and patient engagement by offering digital tools, including electronic vouchers, co-pay savings, and messaging services.
Phreesia Inc operates on a software-as-a-service (SaaS) business model, offering a patient intake platform for healthcare organizations. They provide electronic patient registration, secure data collection, and customizable workflows to streamline the check-in process. Their revenue is generated through subscription fees paid by healthcare providers for utilizing their platform and services.
Rite Aid Corp operates as a retail pharmacy chain, offering a range of healthcare products and services. Their business model revolves around providing prescription medications, over-the-counter drugs, personal care items, and general merchandise to customers through their physical store locations. Rite Aid also offers pharmacy benefit management services and operates walk-in clinics for basic medical services.
Sources:
Veradigm Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Veradigm Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.